Sintx Technologies (SINT) EBITDA Margin (2013 - 2026)
Sintx Technologies (SINT) posted EBITDA Margin of 843.95% for Q1 2026, down 5.58% on a QoQ basis from 799.31% in Q4 2025, and down 19815.0% year-over-year from N/an in Q1 2025.
Analysis
Sintx Technologies (SINT) EBITDA Margin (2013 - 2026) Analysis & Trends
Sintx Technologies has reported EBITDA Margin for 14 years, with the latest figure at 843.95% in Q1 2026.
- On a quarterly basis, EBITDA Margin fell 19815.0% year-over-year to 843.95% in Q1 2026; TTM through Mar 2026 was 1121.96%, a 60686.0% decrease from a year earlier, with the FY2025 full-year figure at 1053.14%, down 56658.0% from the prior year.
- EBITDA Margin was 843.95% for Q1 2026 at Sintx Technologies, down from 799.31% in the prior quarter.
- The five-year high for EBITDA Margin was 301.88% in Q4 2023, with the low at 2232.56% in Q1 2022.
- Average EBITDA Margin over 5 years is 833.56%, with a median of 659.93% recorded in 2023.
- The sharpest annual moves came in 2023 and 2025: EBITDA Margin surged 157263 bps in 2023, then slumped 144942 bps in 2025.
- Over 5 years, EBITDA Margin stood at 376.6% in 2022, then advanced by 20 bps to 301.88% in 2023, then dropped by 6 bps to 319.56% in 2024, then slumped by 150 bps to 799.31% in 2025, then dropped by 6 bps to 843.95% in 2026.
- The last three EBITDA Margin figures came in at 843.95% (Q1 2026), 799.31% (Q4 2025), and 1612.98% (Q3 2025), per Business Quant data.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBITDA Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 183.04 Bn | 177.44 Bn | 7.27 Bn | 13.44% |
| 2 | Intuitive Surgical | 125.02 Bn | 119.81 Bn | 1.96 Bn | 33.60% |
| 3 | Medtronic | 117.84 Bn | 109.02 Bn | 6.34 Bn | 18.08% |
| 4 | Stryker | 105.50 Bn | 102.02 Bn | 4.50 Bn | 25.18% |
| 5 | Boston Scientific | 66.27 Bn | 65.73 Bn | 3.85 Bn | 21.65% |
| 6 | Edwards Lifesciences | 49.60 Bn | 45.35 Bn | 1.35 Bn | 29.48% |
| 7 | Alcon | 33.70 Bn | 32.24 Bn | 1.68 Bn | 0.40% |
| 8 | Dexcom | 32.06 Bn | 30.11 Bn | 830.00 Mn | 24.33% |
| 9 | Steris | 21.02 Bn | 20.54 Bn | 684.20 Mn | 19.15% |
| 10 | Sintx Technologies | 8.73 Mn | 8.73 Mn | - | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Mar 31, 2026 | -843.95% |
| Dec 31, 2025 | -799.31% |
| Sep 30, 2025 | -1,612.98% |
| Jun 30, 2025 | -1,764.90% |
| Mar 31, 2025 | -645.80% |
| Dec 31, 2024 | -319.56% |
| Sep 30, 2024 | -802.00% |
| Jun 30, 2024 | -315.48% |
| Mar 31, 2024 | -465.36% |
| Dec 31, 2023 | -301.88% |
| Sep 30, 2023 | -533.04% |
| Jun 30, 2023 | -681.89% |
| Mar 31, 2023 | -659.93% |
| Dec 31, 2022 | -376.60% |
| Sep 30, 2022 | -655.63% |
| Jun 30, 2022 | -1,159.58% |
| Mar 31, 2022 | -2,232.56% |
| Dec 31, 2021 | -1,570.30% |
| Sep 30, 2021 | -1,182.01% |
| Jun 30, 2021 | -2,339.60% |